These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38731797)

  • 21. Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes.
    Gruber N; Rathaus M; Ron I; Livne R; Sheinvald S; Barhod E; Hemi R; Tirosh A; Pinhas-Hamiel O; Tirosh A
    Diabetologia; 2022 Feb; 65(2):366-374. PubMed ID: 34806114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
    Tanaka M; Takahashi S; Higashiura Y; Sakai A; Koyama M; Saitoh S; Shimamoto K; Ohnishi H; Furuhashi M
    J Diabetes Investig; 2022 May; 13(5):878-888. PubMed ID: 34889064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.
    Hu W; Qiao J
    Endocrine; 2011 Oct; 40(2):196-202. PubMed ID: 21720879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
    Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
    PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.
    Wang CP; Hsu CC; Hung WC; Yu TH; Wu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
    BMC Cardiovasc Disord; 2019 Jun; 19(1):153. PubMed ID: 31234795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study.
    Chan KH; Song Y; Hsu YH; You NC; F Tinker L; Liu S
    Obesity (Silver Spring); 2010 Sep; 18(9):1812-20. PubMed ID: 20111020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.
    Furuhashi M; Sakuma I; Morimoto T; Higashiura Y; Sakai A; Matsumoto M; Sakuma M; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
    Front Endocrinol (Lausanne); 2020; 11():575557. PubMed ID: 33071982
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between vitamin D and glycaemic parameters in a multi-ethnic cohort of postmenopausal women with type 2 diabetes in Saudi Arabia.
    Alharazy S; Alissa E; Lanham-New S; Naseer MI; Chaudhary AG; Robertson MD
    BMC Endocr Disord; 2021 Aug; 21(1):162. PubMed ID: 34380489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait.
    Alramah T; Cherian P; Al-Khairi I; Abu-Farha M; Thanaraj TA; Albatineh AN; Safadi F; Ali H; Abdul-Ghani M; Tuomilehto J; Koistinen HA; Al-Mulla F; Abubaker J
    Front Endocrinol (Lausanne); 2024; 15():1392675. PubMed ID: 38711986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.
    Ibarretxe D; Girona J; Plana N; Cabré A; Heras M; Ferré R; Merino J; Vallvé JC; Masana L
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):875-880. PubMed ID: 26141940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels.
    Khalyfa A; Bhushan B; Hegazi M; Kim J; Kheirandish-Gozal L; Bhattacharjee R; Capdevila OS; Gozal D
    Lipids Health Dis; 2010 Feb; 9():18. PubMed ID: 20156355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population.
    Ayina CN; Noubiap JJ; Etoundi Ngoa LS; Boudou P; Gautier JF; Mengnjo MK; Mbanya JC; Sobngwi E
    Lipids Health Dis; 2016 May; 15():96. PubMed ID: 27189377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area].
    Jing Y; Jin S; Qiao R; Fang J
    Wei Sheng Yan Jiu; 2015 Jul; 44(4):581-5. PubMed ID: 26454955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
    Furuhashi M; Sakuma I; Morimoto T; Higashiura Y; Sakai A; Matsumoto M; Sakuma M; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
    Cardiovasc Diabetol; 2020 Jun; 19(1):89. PubMed ID: 32539832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Change and correlated factors of fasting level of the plasma endotoxin in subjects with different glucose tolerances and body mass indices].
    Liu YH; Zhao TY; Hou LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):769-73, 778. PubMed ID: 24325109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
    Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
    Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.
    Kelly CB; Hookham MB; Yu JY; Lockhart SM; Du M; Jenkins AJ; Nankervis A; Hanssen KF; Henriksen T; Garg SK; Hammad SM; Scardo JA; Aston CE; Patterson CC; Lyons TJ
    Diabetologia; 2017 Dec; 60(12):2514-2524. PubMed ID: 28875223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults.
    Djoussé L; Khawaja O; Bartz TM; Biggs ML; Ix JH; Zieman SJ; Kizer JR; Tracy RP; Siscovick DS; Mukamal KJ
    Diabetes Care; 2012 Aug; 35(8):1701-7. PubMed ID: 22584136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study.
    Meeks KAC; Stronks K; Adeyemo A; Addo J; Bahendeka S; Beune E; Owusu-Dabo E; Danquah I; Galbete C; Henneman P; Klipstein-Grobusch K; Mockenhaupt FP; Osei K; Schulze MB; Spranger J; Smeeth L; Agyemang C
    Diabetologia; 2017 May; 60(5):854-864. PubMed ID: 28144712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.